MAPK3 and systemic lupus erythematosus: The up‐regulation of miR‐497 is involved in the negative modulation of Raf1 and Erk1 protein levels, but not in Erk258 which could be a determining factor in the inhibition of the Erk pathway and therefore as intermediary of SLE progression.